Regulatory News
Friday, December 2, 2016
BRIEF-Neuroderm announces top-line results of pilot PK trial
* Neuroderm announces top-line results of pilot PK trial
comparing ND0701 with commercial apomorphine
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment